In human pancreatic cancer, vimentin and fibronectin are up-regulated in high-grade tumors and within poorly differentiated areas of low-grade tumors, with a concurrent decrease in E-cadherin expression. This evidence concerns the gene CDH1 and familial pancreatic carcinoma.